Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123685196 | 12368519 | 6 | F | 2016 | 20160718 | 20160513 | 20160802 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL001536 | VALIDUS | 0.00 | Y | 0.00000 | 20160802 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123685196 | 12368519 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | UNK | U | 17963 | |||||||||
123685196 | 12368519 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO (ONCE A MONTH) | Y | 0 | 40 | MG | |||||||
123685196 | 12368519 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK, SINGLE/ONCE | Y | 0 | |||||||||
123685196 | 12368519 | 4 | SS | PAMIDRONATE | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
123685196 | 12368519 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 6 | C | EZETROL | EZETIMIBE | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 9 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 10 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 11 | C | LASIX | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
123685196 | 12368519 | 12 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123685196 | 12368519 | 1 | Product used for unknown indication |
123685196 | 12368519 | 2 | Acromegaly |
123685196 | 12368519 | 3 | Acromegaly |
123685196 | 12368519 | 4 | Blood calcium increased |
123685196 | 12368519 | 5 | Product used for unknown indication |
123685196 | 12368519 | 6 | Product used for unknown indication |
123685196 | 12368519 | 7 | Product used for unknown indication |
123685196 | 12368519 | 8 | Product used for unknown indication |
123685196 | 12368519 | 9 | Product used for unknown indication |
123685196 | 12368519 | 10 | Product used for unknown indication |
123685196 | 12368519 | 11 | Product used for unknown indication |
123685196 | 12368519 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123685196 | 12368519 | HO |
123685196 | 12368519 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123685196 | 12368519 | Blood pressure increased | |
123685196 | 12368519 | Chills | |
123685196 | 12368519 | Dyspnoea | |
123685196 | 12368519 | Dyspnoea exertional | |
123685196 | 12368519 | Feeling abnormal | |
123685196 | 12368519 | Injection site pain | |
123685196 | 12368519 | Injection site swelling | |
123685196 | 12368519 | Night sweats | |
123685196 | 12368519 | Platelet count decreased | |
123685196 | 12368519 | Pulmonary embolism | |
123685196 | 12368519 | Pyrexia | |
123685196 | 12368519 | Sepsis | |
123685196 | 12368519 | Thrombosis | |
123685196 | 12368519 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123685196 | 12368519 | 2 | 20111217 | 20160718 | 0 | |
123685196 | 12368519 | 3 | 20110902 | 20110902 | 0 | |
123685196 | 12368519 | 4 | 20160322 | 0 |